About

About Galaxy Diagnostics

Learn about our mission, values, and the specialists empowering infectious disease diagnostics for hospitals and laboratories.

Inside the lab

Clinical science that scales with your operations.

Our Raleigh and Lyon application studios combine biosafety level-3 labs with automation suites, letting partners validate workflows before hardware ships. Every program blends regulatory expertise with design thinking so diagnostics reach patients faster.

Average go-live
42 days

From site survey to first patient samples.

Sample capacity
4.8k / day

Scalable molecular throughput per hub.

Support satisfaction
98%

Post-install CSAT from clinical lab partners.

Book a diagnostic workshop
GalaxyDiag scientists collaborating inside a molecular diagnostics lab.

99.4% uptime

Remote monitoring across 180+ connected analysers.

12 assay launches

Co-developed with reference labs on three continents.

Mission

Accelerating the infectious disease answer for every patient journey.

GalaxyDiag partners with hospitals, public health agencies, and specialty labs to deliver diagnostics that combine scientific rigor with operational excellence. We integrate assay innovation, instrument engineering, and frontline clinical expertise to keep modern laboratories ahead of emerging threats.

  • ISO 15189 manufacturing and quality systems across every product line.
  • Global infectious disease surveillance data informing each release.
  • 24/7 application specialists embedded with our customers.

What partnering labs experience

Immersive validation suites, modular hardware, and embedded data services give your teams clarity long before go-live day.

Lab automation suite with robotic sample handlers.

Automation studio

Dry-run every assay on our modular lines to confirm sample logistics, LIS integrations, and compliance checkpoints.

  • 30-day install blueprint included.
  • Clinical validation kits prepackaged.
Team reviewing diagnostic performance dashboards.

Partner insights lounge

Walk through decision dashboards that translate instrumentation data into actionable LabOps and financial models.

  • Benchmark peers across continents.
  • Forecast reagent usage in minutes.
Specialists coordinating outbreak response plans.

Contingency response theatre

Simulate outbreak surges with our response playbooks, surge kits, and 24/7 command center protocols.

  • Scenario labs staffed year-round.
  • Regulatory notifications templated.

Values

Patient-first science

We measure every launch by the time-to-treatment and public health impact it unlocks.

Operational trust

From sample accessioning to report delivery, our platforms are built for predictable uptime and regulatory clarity.

Collaborative innovation

We co-develop with multi-disciplinary teams—clinicians, epidemiologists, data scientists—to solve real laboratory bottlenecks.

How we work

  1. 1

    Co-discovery sprint

    Jointly map your infectious disease strategy, throughput targets, and compliance milestones.

  2. 2

    Integrated deployment

    Deploy modular analysers, assays, and middleware with onsite validation and digital training playbooks.

  3. 3

    Lifecycle partnership

    Dedicated success managers, remote monitoring, and periodic LabOps reviews keep your roadmap on track.

Certifications & partners

ISO 15189 & ISO 13485

Audited quality management systems supporting assay design, manufacturing, and field service.

CE-IVD & FDA programs

Regulatory pathways spanning CE-marked respiratory panels and FDA 510(k) submissions in progress.

Strategic alliances

Partnerships with leading academic virology labs, antimicrobial stewardship consortia, and bioinformatics teams.

Risk-free onboarding program

Every GalaxyDiag partnership starts with a transition squad, on-site engineering, and continuous adoption coaching so you can prove value before scaling spend.

  • Dedicated transition manager assigned on day one.
  • Performance-linked SLAs covering uptime and assay delivery.
  • On-demand clinical consults included in subscription.

Leadership snapshot

Dr. Amina Kwan

Chief Scientific Officer

Medical microbiologist with 18 years of translational research leading syndromic panel development.

Marc Tremblay

VP, Laboratory Operations

Former hospital LabOps director specialising in high-throughput molecular automation and Lean rollouts.

Elena Dubois

Head of Clinical Partnerships

Builds global partnerships connecting public health agencies with GalaxyDiag epidemic intelligence.

Meet the extended team